281 related articles for article (PubMed ID: 38362864)
1. The role of the microbiome in liver disease.
Schöler D; Schnabl B
Curr Opin Gastroenterol; 2024 May; 40(3):134-142. PubMed ID: 38362864
[TBL] [Abstract][Full Text] [Related]
2. Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD).
Benedé-Ubieto R; Cubero FJ; Nevzorova YA
Gut Microbes; 2024; 16(1):2331460. PubMed ID: 38512763
[TBL] [Abstract][Full Text] [Related]
3. Promises of microbiome-based therapies.
Bajaj JS; Ng SC; Schnabl B
J Hepatol; 2022 Jun; 76(6):1379-1391. PubMed ID: 35589257
[TBL] [Abstract][Full Text] [Related]
4. Gut Microbiome-Centered Therapies for Alcohol-Associated Liver Disease.
Ranjbarian T; Schnabl B
Semin Liver Dis; 2023 Aug; 43(3):311-322. PubMed ID: 37527781
[TBL] [Abstract][Full Text] [Related]
5. Microbiome as a therapeutic target in alcohol-related liver disease.
Sarin SK; Pande A; Schnabl B
J Hepatol; 2019 Feb; 70(2):260-272. PubMed ID: 30658727
[TBL] [Abstract][Full Text] [Related]
6. Are Probiotics Effective in Targeting Alcoholic Liver Diseases?
Hong M; Han DH; Hong J; Kim DJ; Suk KT
Probiotics Antimicrob Proteins; 2019 Jun; 11(2):335-347. PubMed ID: 29687200
[TBL] [Abstract][Full Text] [Related]
7. The gut-liver axis in liver disease: Pathophysiological basis for therapy.
Albillos A; de Gottardi A; Rescigno M
J Hepatol; 2020 Mar; 72(3):558-577. PubMed ID: 31622696
[TBL] [Abstract][Full Text] [Related]
8. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.
Ferrere G; Wrzosek L; Cailleux F; Turpin W; Puchois V; Spatz M; Ciocan D; Rainteau D; Humbert L; Hugot C; Gaudin F; Noordine ML; Robert V; Berrebi D; Thomas M; Naveau S; Perlemuter G; Cassard AM
J Hepatol; 2017 Apr; 66(4):806-815. PubMed ID: 27890791
[TBL] [Abstract][Full Text] [Related]
9. Altered gut microbiota in hepatocellular carcinoma: Insights into the pathogenic mechanism and preclinical to clinical findings.
Das BK
APMIS; 2022 Dec; 130(12):719-740. PubMed ID: 36321381
[TBL] [Abstract][Full Text] [Related]
10. COMPARISON OF GUT MICROBIOTA IN ALCOHOLIC AND METABOLIC-DYSFUNCION ASSOCIATED STEATOTIC LIVER DISEASE IN ANIMAL MODELS.
Perlin CM; Longo L; Thoen RU; Uribe-Cruz C; Álvares-DA-Silva MR
Arq Gastroenterol; 2024; 61():e23100. PubMed ID: 38511793
[TBL] [Abstract][Full Text] [Related]
11. Targeting the gut microbiota to treat alcoholic liver diseases: evidence and promises.
Leclercq S; de Timary P; Stärkel P
Acta Gastroenterol Belg; 2020; 83(4):616-621. PubMed ID: 33321019
[TBL] [Abstract][Full Text] [Related]
12. Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies.
Koning M; Herrema H; Nieuwdorp M; Meijnikman AS
Gut Microbes; 2023; 15(1):2226922. PubMed ID: 37610978
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiome in HCC - Mechanisms, diagnosis and therapy.
Schwabe RF; Greten TF
J Hepatol; 2020 Feb; 72(2):230-238. PubMed ID: 31954488
[TBL] [Abstract][Full Text] [Related]
14. Microbiome-Based Metabolic Therapeutic Approaches in Alcoholic Liver Disease.
Hyun JY; Kim SK; Yoon SJ; Lee SB; Jeong JJ; Gupta H; Sharma SP; Oh KK; Won SM; Kwon GH; Cha MG; Kim DJ; Ganesan R; Suk KT
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955885
[TBL] [Abstract][Full Text] [Related]
15. Alcohol or Gut Microbiota: Who Is the Guilty?
Meroni M; Longo M; Dongiovanni P
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540133
[TBL] [Abstract][Full Text] [Related]
16. Role of gut bacterial and non-bacterial microbiota in alcohol-associated liver disease: Molecular mechanisms, biomarkers, and therapeutic prospective.
Zafari N; Velayati M; Fahim M; Maftouh M; Pourali G; Khazaei M; Nassiri M; Hassanian SM; Ghayour-Mobarhan M; Ferns GA; Kiani MA; Avan A
Life Sci; 2022 Sep; 305():120760. PubMed ID: 35787997
[TBL] [Abstract][Full Text] [Related]
17. Microbiota, Liver Diseases, and Alcohol.
Cassard AM; Gérard P; Perlemuter G
Microbiol Spectr; 2017 Aug; 5(4):. PubMed ID: 28840806
[TBL] [Abstract][Full Text] [Related]
18. Microbiota, a key player in alcoholic liver disease.
Cassard AM; Ciocan D
Clin Mol Hepatol; 2018 Jun; 24(2):100-107. PubMed ID: 29268595
[TBL] [Abstract][Full Text] [Related]
19. Microbiota-based treatments in alcoholic liver disease.
Sung H; Kim SW; Hong M; Suk KT
World J Gastroenterol; 2016 Aug; 22(29):6673-82. PubMed ID: 27547010
[TBL] [Abstract][Full Text] [Related]
20. The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease.
Chu H; Duan Y; Lang S; Jiang L; Wang Y; Llorente C; Liu J; Mogavero S; Bosques-Padilla F; Abraldes JG; Vargas V; Tu XM; Yang L; Hou X; Hube B; Stärkel P; Schnabl B
J Hepatol; 2020 Mar; 72(3):391-400. PubMed ID: 31606552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]